BTSG vs LFST

For growth investors, BrightSpring Health Services, Inc.

Common Stock (BTSG) is the stronger pick with 14. 6% revenue growth year-over-year, versus 13. 9% for LifeStance Health Group, Inc. (LFST). BrightSpring Health Services, Inc. Common Stock (BTSG) offers the better valuation at 60. 6x trailing P/E (33. 9x forward), making it the more compelling value choice. Analysts rate BrightSpring Health Services, Inc. Common Stock (BTSG) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, BrightSpring Health Services, Inc.

Common Stock (BTSG) is the cheapest at 60. 6x versus LifeStance Health Group, Inc. at 368. 0x. On forward P/E, BrightSpring Health Services, Inc. Common Stock is actually cheaper at 33. 9x.

Over the past 5 years, BrightSpring Health Services, Inc.

Common Stock (BTSG) delivered a total return of +379. 5%, compared to -66. 4% for LifeStance Health Group, Inc. (LFST). Over 10 years, the gap is even starker: BTSG returned +379. 5% versus LFST's -66. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), LifeStance Health Group, Inc.

(LFST) is the lower-risk stock at 1. 20β versus BrightSpring Health Services, Inc. Common Stock's 1. 46β — meaning BTSG is approximately 22% more volatile than LFST relative to the S&P 500. On balance sheet safety, LifeStance Health Group, Inc. (LFST) carries a lower debt/equity ratio of 13% versus 151% for BrightSpring Health Services, Inc. Common Stock — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), BrightSpring Health Services, Inc.

Common Stock (BTSG) is pulling ahead at 14. 6% versus 13. 9% for LifeStance Health Group, Inc. (LFST). On earnings-per-share growth, the picture is similar: BrightSpring Health Services, Inc. Common Stock grew EPS 1029% year-over-year, compared to 113. 3% for LifeStance Health Group, Inc.. Over a 3-year CAGR, BTSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

BrightSpring Health Services, Inc.

Common Stock (BTSG) is the more profitable company, earning 1. 5% net margin versus 0. 7% for LifeStance Health Group, Inc. — meaning it keeps 1. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BTSG leads at 3. 2% versus 1. 8% for LFST. At the gross margin level — before operating expenses — LFST leads at 28. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, BrightSpring Health Services, Inc.

Common Stock (BTSG) trades at 33. 9x forward P/E versus 100. 7x for LifeStance Health Group, Inc. — 66. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LFST: 26. 4% to $9. 30.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, BrightSpring Health Services, Inc.

Common Stock (BTSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+379. 5% 10Y return). Both have compounded well over 10 years (BTSG: +379. 5%, LFST: -66. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.